159 related articles for article (PubMed ID: 29953319)
41. Role of polymorphic Fc receptor Fc gammaRIIa in cytokine release and adverse effects of murine IgG1 anti-CD3/T cell receptor antibody (WT31).
Tax WJ; Tamboer WP; Jacobs CW; Frenken LA; Koene RA
Transplantation; 1997 Jan; 63(1):106-12. PubMed ID: 9000670
[TBL] [Abstract][Full Text] [Related]
42. Human IgG3 with extended half-life does not improve Fc-gamma receptor-mediated cancer antibody therapies in mice.
Braster R; Grewal S; Visser R; Einarsdottir HK; van Egmond M; Vidarsson G; Bögels M
PLoS One; 2017; 12(5):e0177736. PubMed ID: 28542406
[TBL] [Abstract][Full Text] [Related]
43. Characterization of monoclonal antibodies to human interferon-gamma and their application to enzyme-linked immunosorbent assay (ELISA).
Hirai M; Terano Y; Miura Y
Jpn J Med Sci Biol; 1989 Aug; 42(4):127-36. PubMed ID: 2517544
[TBL] [Abstract][Full Text] [Related]
44. Specific anti-Neospora caninum IgG1 and IgG2 antibody responses during gestation in naturally infected cattle and their relationship with gamma interferon production.
Almería S; Nogareda C; Santolaria P; Garcia-Ispierto I; Yániz JL; López-Gatius F
Vet Immunol Immunopathol; 2009 Jul; 130(1-2):35-42. PubMed ID: 19201036
[TBL] [Abstract][Full Text] [Related]
45. A role for autoantibodies in enhancement of pro-inflammatory cytokine responses to a self-antigen, thyroid peroxidase.
Nielsen CH; Brix TH; Leslie RG; Hegedüs L
Clin Immunol; 2009 Nov; 133(2):218-27. PubMed ID: 19726232
[TBL] [Abstract][Full Text] [Related]
46. Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa.
Okazaki A; Shoji-Hosaka E; Nakamura K; Wakitani M; Uchida K; Kakita S; Tsumoto K; Kumagai I; Shitara K
J Mol Biol; 2004 Mar; 336(5):1239-49. PubMed ID: 15037082
[TBL] [Abstract][Full Text] [Related]
47. Engineering therapeutic antibodies for improved function.
Presta LG; Shields RL; Namenuk AK; Hong K; Meng YG
Biochem Soc Trans; 2002 Aug; 30(4):487-90. PubMed ID: 12196120
[TBL] [Abstract][Full Text] [Related]
48. The role of antibody isotype in IFN-gamma and IL-2 production during anti-CD3-induced T cell proliferation.
Frenken LA; Koene RA; Tax WJ
Transplantation; 1991 Apr; 51(4):881-7. PubMed ID: 1826571
[TBL] [Abstract][Full Text] [Related]
49. Different cytokine profiles released by CD4+ and CD8+ tumor-draining lymph node cells involved in mediating tumor regression.
Aruga A; Aruga E; Cameron MJ; Chang AE
J Leukoc Biol; 1997 Apr; 61(4):507-16. PubMed ID: 9103238
[TBL] [Abstract][Full Text] [Related]
50. Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies.
Galatiuc C; Gherman M; Metes D; Sulica A; DeLeo A; Whiteside TL; Herberman RB
Cell Immunol; 1995 Jul; 163(2):167-77. PubMed ID: 7606790
[TBL] [Abstract][Full Text] [Related]
51. High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G.
Preithner S; Elm S; Lippold S; Locher M; Wolf A; da Silva AJ; Baeuerle PA; Prang NS
Mol Immunol; 2006 Mar; 43(8):1183-93. PubMed ID: 16102830
[TBL] [Abstract][Full Text] [Related]
52. Anti-FcγRIIB (CD32) Antibodies Differentially Modulate Murine FVIII-Specific Recall Response in vitro.
Vollack N; Friese J; Bergmann S; Cragg MS; Tiede A; Werwitzke S
Scand J Immunol; 2017 Aug; 86(2):91-99. PubMed ID: 28561280
[TBL] [Abstract][Full Text] [Related]
53. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.
Zhang Z; Zhang M; Goldman CK; Ravetch JV; Waldmann TA
Cancer Res; 2003 Oct; 63(19):6453-7. PubMed ID: 14559836
[TBL] [Abstract][Full Text] [Related]
54. Different types of FCgamma-receptors are involved in anti-Lewis Y antibody induced effector functions in vitro.
Dettke M; Loibner H
Br J Cancer; 2000 Jan; 82(2):441-5. PubMed ID: 10646902
[TBL] [Abstract][Full Text] [Related]
55. Enhanced Effector Functions Due to Antibody Defucosylation Depend on the Effector Cell Fcγ Receptor Profile.
Bruggeman CW; Dekkers G; Bentlage AEH; Treffers LW; Nagelkerke SQ; Lissenberg-Thunnissen S; Koeleman CAM; Wuhrer M; van den Berg TK; Rispens T; Vidarsson G; Kuijpers TW
J Immunol; 2017 Jul; 199(1):204-211. PubMed ID: 28566370
[TBL] [Abstract][Full Text] [Related]
56. The in vivo effects of neutralizing antibodies against IFN-gamma, IL-4, or IL-10 on the humoral immune response in young and aged mice.
Dobber R; Tielemans M; Nagelkerken L
Cell Immunol; 1995 Feb; 160(2):185-92. PubMed ID: 7720078
[TBL] [Abstract][Full Text] [Related]
57. CD52-Negative NK Cells Are Abundant in the Liver and Less Susceptible to Alemtuzumab Treatment.
Hotta R; Ohira M; Matsuura T; Muraoka I; Tryphonopoulos P; Fan J; Tekin A; Selvaggi G; Levi D; Ruiz P; Ricordi C; Vianna R; Ohdan H; Waldmann H; Tzakis AG; Nishida S
PLoS One; 2016; 11(8):e0161618. PubMed ID: 27560943
[TBL] [Abstract][Full Text] [Related]
58. Induction of IgG rheumatoid factor (RF) production by antibody-antibody (RF-like) immune complexes: the role of T cells, complement and Fc gamma receptors.
Nordström E; Möller E; Abedi-Valugerdi M
J Autoimmun; 1998 Apr; 11(2):131-40. PubMed ID: 9650092
[TBL] [Abstract][Full Text] [Related]
59. Signal transduction via Fc gamma R and Mac-1 alpha-chain in monocytes and polymorphonuclear leucocytes.
Gadd SJ; Eher R; Majdic O; Knapp W
Immunology; 1994 Apr; 81(4):611-7. PubMed ID: 8039812
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of macrophage-activating cytokines is beneficial in the acute septic response.
Redmond HP; Chavin KD; Bromberg JS; Daly JM
Ann Surg; 1991 Oct; 214(4):502-8; discussion 508-9. PubMed ID: 1659339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
